Skip to main content
Log in

Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background This study describes the analysis of secondary outcomes from a previously published randomised controlled trial, which assessed the effects of pharmaceutical care on medication adherence, persistence and bone turnover markers. The main focus of this manuscript is the effect of the provision of pharmaceutical care on these secondary outcomes, and details on the design of the intervention provided, the osteoporosis care plan and materials used to deliver the intervention. Objectives To evaluate the effects of pharmaceutical care on knowledge, quality of life (QOL) and satisfaction of postmenopausal osteoporotic women prescribed bisphosphonates, and their associating factors. Setting Randomised controlled trial, performed at an osteoporosis clinic of a tertiary hospital in Malaysia. Methods Postmenopausal women diagnosed with osteoporosis (T-score ≤−2.5/lowtrauma fracture), just been prescribed weekly alendronate/risedronate were randomly allocated to receive intervention or standard care (controls). Intervention participants received a medication review, education on osteoporosis, risk factors, lifestyle modifications, goals of therapy, side effects and the importance of medication adherence at months 0, 3, 6 and 12. Main outcomes measure Knowledge, QOL and satisfaction. Results A total of 198 postmenopausal osteoporotic women were recruited: intervention = 100 and control = 98. Intervention participants reported significantly higher knowledge scores at months 3 (72.50 vs. 62.50 %), 6 (75.00 vs. 65.00 %) and 12 (78.75 vs. 68.75 %) compared to control participants. QOL scores were also lower (which indicates better QOL) at months 3 (29.33 vs. 38.41), 6 (27.50 vs. 36.56) and 12 (27.53 vs. 37.56) compared to control participants. Similarly, satisfaction score was higher in intervention participants (93.67 vs. 84.83 %). More educated women, with back pain, who were provided pharmaceutical care had better knowledge levels. Similarly, older, more educated women, with previous falls and back pain tend to have poorer QOL, whilst women who exercised more frequently and were provided pharmaceutical care had better QOL. Satisfaction also increased as QOL increases and when provided pharmaceutical care. Conclusion The provision of pharmaceutical care improved knowledge, QOL and satisfaction in Malaysian postmenopausal osteoporotic women, showing that pharmacists have the potential to improve patients’ overall bone health. Policymakers should consider placing a clinical pharmacist in the osteoporosis clinic to provide counselling to improve these outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285–9.

    Article  PubMed  CAS  Google Scholar 

  2. Kao PC, P’eng FK. How to reduce the risk factors of osteoporosis in Asia. Chung-Hua I Hsueh Tsa Chih (Chinese Medical Journal) (Taipei). 1995;55(3):209–13.

    CAS  Google Scholar 

  3. Burge R, Dawson-Hughes B, Solomon DH. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22:465–7.

    Article  PubMed  Google Scholar 

  4. Rolnick SJ, Kopher R, Jackson J, Fischer LR, Compo R. What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting. Menopause. 2001;8(2):141–8.

    Article  PubMed  CAS  Google Scholar 

  5. Lai P, Chua SS, Chan SP. A systematic review of interventions by healthcare professionals on community-dwelling postmenopausal women with osteoporosis. Osteoporos Int. 2010;21(10):1637–56.

    Article  PubMed  CAS  Google Scholar 

  6. Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, et al. A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int. 2008;19(12):1733–40.

    Article  PubMed  CAS  Google Scholar 

  7. Nielsen D, Ryg J, Nissen N, Nielsen W, Knold B, Brixen K. Multidisciplinary patient education in groups increases knowledge on osteoporosis: a randomized controlled trial. Scand J Public Health. 2008;36(4):346–52.

    Article  PubMed  Google Scholar 

  8. Estok PJ, Sedlak CA, Doheny MO, Hall R. Structural model for osteoporosis preventing behavior in postmenopausal women. Nurs Res. 2007;56(3):148–58.

    Article  PubMed  Google Scholar 

  9. Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Rowe BH. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ. 2008;178(5):569–75.

    PubMed  Google Scholar 

  10. Sedlak CA, Doheny MO, Estok PJ, Zeller RA. Tailored interventions to enhance osteoporosis prevention in women. Orthop Nurs. 2005;24(4):270–6.

    Article  PubMed  Google Scholar 

  11. Binder EF, Brown M, Sinacore DR, Steger-May K, Yarasheski KE, Schechtman KB. Effects of extended outpatient rehabilitation after hip fracture: a randomized controlled trial. JAMA. 2004;292(7):837–46.

    Article  PubMed  CAS  Google Scholar 

  12. Papaioannou A, Adachi JD, Winegard K, Ferko N, Parkinson W, Cook RJ, et al. Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures. Osteoporos Int. 2003;14(8):677–82.

    Article  PubMed  CAS  Google Scholar 

  13. Bravo G, Gauthier P, Roy PM, Payette H, Gaulin P, Harvey M, et al. Impact of a 12-month exercise program on the physical and psychological health of osteopenic women. J Am Geriatr Soc. 1996;44(7):756–62.

    PubMed  CAS  Google Scholar 

  14. Malmros B, Mortenson L, Jensen MB, Charles P. Positive effects of physiotherapy on chronic pain and performance in osteoporosis. Osteoporos Int. 1998;8:215–21.

    Article  PubMed  CAS  Google Scholar 

  15. Alp A, Kanat E, Yurtkuran M. Efficacy of a self-management program for osteoporotic subjects. Am J Phys Med Rehabil. 2007;86(8):633–40.

    Article  PubMed  Google Scholar 

  16. Guilera M, Fuentes M, Grifols M, Ferrer J, Badia X. Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study. Osteoporos Int. 2006;17(5):664–71.

    Article  PubMed  CAS  Google Scholar 

  17. Hongo M, Itoi E, Sinaki M, Miyakoshi N, Shimada Y, Maekawa S, et al. Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial. Osteoporos Int. 2007;18(10):1389–95.

    Article  PubMed  CAS  Google Scholar 

  18. Tsauo JY, Leu WS, Chen YT, Yang RS. Effects on function and quality of life of postoperative home-based physical therapy for patients with hip fracture. Arch Phys Med Rehabil. 2005;86(10):1953–7.

    Article  PubMed  Google Scholar 

  19. Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Morrish DW. Use of a case manager to improve osteoporosis treatment after hip fracture—results of a randomized controlled trial. Arch Int Med. 2007;167(19):2110–5.

    Article  Google Scholar 

  20. van Haastregt JCM, Diederiks JPM, van Rossum E, de Witte LP, Voorhoeve PM, Crebolder HF. Effects of a programme of multifactorial home visits on falls and mobility impairments in elderly people at risk: a randomized controlled trial. BMJ. 2000;321:994–8.

    Article  PubMed  Google Scholar 

  21. Elley CR, Robertson MC, Garrett S, Kerse NM, McKinlay E, Lawton B, et al. Effectiveness of falls-and-fracture nurse coordinator to reduce falls: a randomized, controlled trial of at-risk older adults. J Am Geriatr Soc. 2008;56(8):1383–9.

    Article  PubMed  Google Scholar 

  22. Carter ND, Khan KM, McKay HA, Petit MA, Waterman C, Heinonen A, et al. Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: a randomized controlled trial. CMAJ. 2002;167(9):997–1004.

    PubMed  Google Scholar 

  23. Delmas PD, Vrijens B, Eastell R, Roux C, Pols HAP, Ringe JD, et al. Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis. J Clin Endrocrinol Metab. 2007;92(4):1296–304.

    Article  CAS  Google Scholar 

  24. Feldstein AC, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C, et al. Electronic medical record reminder improves osteoporosis management after a fracture: a randomised controlled trial. J Am Geriatr Soc. 2006;54(3):450–7.

    Article  PubMed  Google Scholar 

  25. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from project ImPACT: osteoporosis. J Am Pharm Assoc (Wash). 2004;44(2):152–60.

    Article  Google Scholar 

  26. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc (Wash). 2004;44(2):161–7.

    Article  Google Scholar 

  27. Gray M, Rajaei-Dahkordi Z, Ewan M, Wysocki R. Investigating the potential contribution of community pharmacists in identifying, understanding and meeting the bone health needs of patients in collaboration with GPs. IJPP. 2002;10(suppl):R34.

    Google Scholar 

  28. Newman ED, Hanus P. Improved bone health behavior using community pharmacists as educators—the geisinger health system community pharmacist osteoporosis education program. Dis Manage Health Outcomes. 2001;9(6):329–35.

    Article  Google Scholar 

  29. Lai P, Chua SS, Chew YY, Chan SP. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women. J Clin Pharm Ther. 2011;36(5):557–67.

    Article  PubMed  CAS  Google Scholar 

  30. Lai P, Chua SS, Chan SP. Pharmaceutical care issues encountered by postmenopausal osteoporotic women prescribed bisphosphonates. J Clin Pharm Ther. 2012;37:536–43.

    Article  PubMed  CAS  Google Scholar 

  31. Dupont WD, Plummer WD. PS. Power and sample size calculation version 3.0 2009 [updated 12 June; cited 2012 30 June]. Available from: http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize.

  32. Lai PSM, Chua SS, Chan SP, Low WY. The validity and reliability of the Malaysian osteoporosis knowledge tool in postmenopausal women. Maturitas. 2008;60(2):122–30.

    Article  PubMed  Google Scholar 

  33. Lai P, Chua SS, Chan SP, Low WY. Validation of the english version of quality of life questionnaire of the european foundation for osteoporosis (QUALEFFO) in Malaysia. Int J Rheum Diseases. 2008;11:421–9.

    Article  Google Scholar 

  34. Lai P, Chua SS, Chan SP, Low WY. Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ) (abstract PP1) 1st hospital pharmacy congress 2008.

  35. Lai PSM, Chua SS, Chan SP, Low WY, Wong ICK. Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ). Maturitas. 2010;65:55–63.

    Article  PubMed  Google Scholar 

  36. Kamatari M, Koto S, Ozawa N, Urao C, Suzuki Y, Akasaka E, et al. Factors affecting long-term compliance of osteoporotic patients with bisphosphonate treatment and QOL assessment in actual practice: alendronate and risedronate. J Bone Min Metab. 2007;25(5):302–9.

    Article  CAS  Google Scholar 

  37. Rizzoli R. Long-term strategy in the management of postmenopausal osteoporosis. Joint Bone Spine. 2007;74:540–3.

    Article  PubMed  Google Scholar 

  38. Zhu K, Devine A, Dick IM, Prince RL. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women. Spine. 2007;32(18):2012–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Professor Ian Chi Kei Wong (Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London) for his feedback on the questionnaire. We also like to extend our appreciation to Dr. David Wu, Statistician (Monash University, Sunway campus, Malaysia) for his advice on statistical procedures. Last but not least, we would like to thank all the research participants for their involvement in this study.

Funding

This project was funded by the Postgraduate Research Fund P0110/2006B, University of Malaya and the Endocrine Research fund, University of Malaya.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pauline Siew Mei Lai.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 207 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, P.S.M., Chua, S.S. & Chan, S.P. Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis. Int J Clin Pharm 35, 629–637 (2013). https://doi.org/10.1007/s11096-013-9784-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-013-9784-x

Keywords

Navigation